These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29291383)

  • 1. Genetic Profiles of Squamous Cell Carcinomas Associated with Recessive Dystrophic Epidermolysis Bullosa Unveil NOTCH and TP53 Mutations and an Increased MYC Expression.
    Sans-DeSanNicolas L; Caratú G; Vidal-Cortés O; Sanchez-Redondo S; Ferrer B; Mancuso F; González-Sanchez E; Pérez-Alea M; McGrail K; Hernandez-Losa J; Bodet D; Vivancos A; Garcia-Patos V; Recio JA
    J Invest Dermatol; 2018 Jun; 138(6):1423-1427. PubMed ID: 29291383
    [No Abstract]   [Full Text] [Related]  

  • 2. Understanding the pathogenesis of recessive dystrophic epidermolysis bullosa squamous cell carcinoma.
    South AP; O'Toole EA
    Dermatol Clin; 2010 Jan; 28(1):171-8. PubMed ID: 19945632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A recurrent nonsense mutation occurring as a de novo event in a patient with recessive dystrophic epidermolysis bullosa.
    Cuadrado-Corrales N; Sánchez-Jimeno C; García M; Ayuso C; De Lucas R; Vicario JL; Conti CJ; Zambruno G; Escamez MJ; Del Rio M
    Dermatology; 2011; 223(3):219-21. PubMed ID: 21849769
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeting the Jak/Signal Transducer and Activator of Transcription 3 Pathway with Ruxolitinib in a Mouse Model of Recessive Dystrophic Epidermolysis Bullosa-Squamous Cell Carcinoma.
    Jacków J; Rami A; Hayashi R; Hansen C; Guo Z; DeLorenzo D; Pappalardo A; Alvarez Cespedes D; Kim AL; Perez-Lorenzo R; Owens DM; Christiano AM
    J Invest Dermatol; 2021 Apr; 141(4):942-946. PubMed ID: 33069729
    [No Abstract]   [Full Text] [Related]  

  • 5. Recessive dystrophic epidermolysis bullosa-associated squamous-cell carcinoma: an enigmatic entity with complex pathogenesis.
    Rodeck U; Uitto J
    J Invest Dermatol; 2007 Oct; 127(10):2295-6. PubMed ID: 17853916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of mutant p53 gene in squamous carcinoma arising in patients with recessive dystrophic epidermolysis bullosa.
    Slater SD; McGrath JA; Hobbs C; Eady RA; McKee PH
    Histopathology; 1992 Mar; 20(3):237-41. PubMed ID: 1563710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on the pathogenesis of squamous cell carcinoma development in recessive dystrophic epidermolysis bullosa.
    Kim M; Murrell DF
    Eur J Dermatol; 2015 Apr; 25 Suppl 1():30-2. PubMed ID: 26083672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Squamous cell cancers in Hallopeau-Siemens recessive dystrophic epidermolysis bullosa].
    Otte HG; Stieler W; Anton-Lamprecht I
    Hautarzt; 1990 Sep; 41(9):494-8. PubMed ID: 2249946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of p53 and p16 tumor suppressor genes in recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma.
    Arbiser JL; Fan CY; Su X; Van Emburgh BO; Cerimele F; Miller MS; Harvell J; Marinkovich MP
    J Invest Dermatol; 2004 Oct; 123(4):788-90. PubMed ID: 15373786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer. An anchor for tumor cell invasion.
    Yuspa SH; Epstein EH
    Science; 2005 Mar; 307(5716):1727-8. PubMed ID: 15774745
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of squamous cell carcinoma in a patient with recessive-type epidermolysis bullosa dystrophica.
    Yamada M; Hatta N; Sogo K; Komura K; Hamaguchi Y; Takehara K
    Dermatol Surg; 2004 Nov; 30(11):1424-9. PubMed ID: 15522026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squamous cell carcinoma secondary to recessive dystrophic epidermolysis bullosa. A report of 4 patients with 17 primary cutaneous malignancies.
    Newman C; Wagner RF; Tyring SK; Spigel GT
    J Dermatol Surg Oncol; 1992 Apr; 18(4):301-5. PubMed ID: 1560154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High levels of type VII collagen expression in recessive dystrophic epidermolysis bullosa cutaneous squamous cell carcinoma keratinocytes increases PI3K and MAPK signalling, cell migration and invasion.
    Pourreyron C; Chen M; McGrath JA; Salas-Alanis JC; South AP; Leigh IM
    Br J Dermatol; 2014 Jun; 170(6):1256-65. PubMed ID: 24641191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Squamous cell carcinoma and recessive dystrophic epidermolysis bullosa].
    Fourel E; Claudy AL
    Ann Dermatol Venereol; 1992; 119(8):563-5. PubMed ID: 1485760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Squamous cell carcinoma in junctional and dystrophic epidermolysis bullosa.
    Weber F; Bauer JW; Sepp N; Högler W; Salmhofer W; Hintner H; Fritsch P
    Acta Derm Venereol; 2001; 81(3):189-92. PubMed ID: 11558875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel lymph node biopsy in recessive dystrophic epidermolysis bullosa and squamous cell carcinoma.
    Perez-Naranjo L; Herrera-Saval A; Garcia-Bravo B; Perez-Bernal AM; Camacho F
    Arch Dermatol; 2005 Jan; 141(1):110-1. PubMed ID: 15655164
    [No Abstract]   [Full Text] [Related]  

  • 17. Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression.
    Pourreyron C; Cox G; Mao X; Volz A; Baksh N; Wong T; Fassihi H; Arita K; O'Toole EA; Ocampo-Candiani J; Chen M; Hart IR; Bruckner-Tuderman L; Salas-Alanis JC; McGrath JA; Leigh IM; South AP
    J Invest Dermatol; 2007 Oct; 127(10):2438-44. PubMed ID: 17495952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of sentinel node biopsy in the management of squamous cell carcinoma arising from recessive dystrophic epidermolysis bullosa.
    Rokunohe A; Nakano H; Aizu T; Kaneko T; Nakajima K; Ikenaga S; Matsuzaki Y; Murai T; Tamai K; Sawamura D
    J Dermatol; 2008 Jun; 35(6):336-40. PubMed ID: 18578710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous manifestation of squamous cell carcinoma in identical twins with epidermolysis bullosa.
    Hosokawa K; Yoshitatsu S; Kakibuchi M; Nishimoto S; Higashiyama M; Yoshikawa K
    Plast Reconstr Surg; 1998 Aug; 102(2):448-9. PubMed ID: 9703083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal aspects of type VII collagen: Implications for dystrophic epidermolysis bullosa and epidermolysis bullosa acquisita.
    Watanabe M; Natsuga K; Shinkuma S; Shimizu H
    J Dermatol; 2018 May; 45(5):515-521. PubMed ID: 29352483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.